HCM
NVAX icon

Harvey Capital Management’s Novavax NVAX Stock Holding History

Harvey Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,980
Closed -$82K – 79
2016
Q3 		$82K Sell
1,980
-28,158
-93% -$3.64M 0.03% 77
2016
Q2 		$4.38M Sell
30,138
-1,250
-4% -$143K 2.19% 19
2016
Q1 		$3.24M Sell
31,388
-895
-3% -$96K 1.57% 21
2015
Q4 		$5.42M Buy
32,283
+1,085
+3% +$167K 2.14% 18
2015
Q3 		$4.41M Buy
31,198
+600
+2% +$135K 1.76% 20
2015
Q2 		$6.66M Sell
30,598
-250
-0.8% -$43.9K 2.25% 18
2015
Q1 		$5.1M Buy
30,848
+1,115
+4% +$181K 1.88% 19
2014
Q4 		$3.53M Buy
29,733
+4,985
+20% +$521K 1.35% 23
2014
Q3 		$2.06M Sell
24,748
-725
-3% -$65.5K 0.81% 35
2014
Q2 		$2.35M Buy
25,473
+125
+0.5% +$11K 0.84% 34
2014
Q1 		$2.3M Buy
25,348
+21,313
+528% +$2.38M 0.92% 31
2013
Q4 		$413K Buy
4,035
+500
+14% +$35.3K 0.17% 62
2013
Q3 		$222K Buy
+3,535
New +$199K 0.11% 54

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Harvey Capital Management's NVAX Position: Q4 2016 in Review

Harvey Capital Management sold out of Novavax (NVAX) in Q4 2016, closing a stake of 1,980 shares — an estimated $82K sold.

Harvey Capital Management first reported a position in NVAX in Q3 2013 and held it in 13 quarters. The position peaked at $6.66M in Q2 2015. 142 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

  • Harvey Capital Management reported no remaining Novavax position as of Q4 2016 after selling out during the quarter.
  • Harvey Capital Management sold 1,980 Novavax shares in Q4 2016, an estimated $82K.
  • Harvey Capital Management first reported a position in Novavax in Q3 2013 and held it in 13 quarters.
  • Harvey Capital Management's Novavax position peaked at $6.66M in Q2 2015.
  • 142 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on Harvey Capital Management's 13F filing for Q4 2016, filed 27 Jan 2017.